Systematic review: patient-reported outcomes in chronic hepatitis C - the impact of liver disease and new treatment regimens
出版年份 2015 全文链接
标题
Systematic review: patient-reported outcomes in chronic hepatitis C - the impact of liver disease and new treatment regimens
作者
关键词
-
出版物
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 41, Issue 6, Pages 497-520
出版商
Wiley
发表日期
2015-01-23
DOI
10.1111/apt.13090
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Patients' preferences and health utility assessment with SF-6D and EQ-5D in patients with chronic hepatitis C treated with sofosbuvir regimens
- (2014) M. Stepanova et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The impact of hepatitis C burden: an evidence-based approach
- (2014) Z. M. Younossi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Multiple Factors Predict Physical Performance in People with Chronic Liver Disease
- (2014) Anthony Loria et al. AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION
- Fatigue during treatment for hepatitis C virus: results of self-reported fatigue severity in two Phase IIb studies of simeprevir treatment in patients with hepatitis C virus genotype 1 infection
- (2014) Jane Scott et al. BMC INFECTIOUS DISEASES
- Lower Pill Burden and Once-Daily Antiretroviral Treatment Regimens for HIV Infection: A Meta-Analysis of Randomized Controlled Trials
- (2014) Jean B. Nachega et al. CLINICAL INFECTIOUS DISEASES
- Effectiveness of Telaprevir and Boceprevir Triple Therapy for Patients with Hepatitis C Virus Infection in a Large Integrated Care Setting
- (2014) Jennifer C. Price et al. DIGESTIVE DISEASES AND SCIENCES
- Treatment for chronic hepatitis C in a cohort of opiate substitution therapy recipients in three Swedish cities – completion rates and efficacy
- (2014) Anna Jerkeman et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Simeprevir With Peginterferon and Ribavirin Leads to High Rates of SVR in Patients With HCV Genotype 1 Who Relapsed After Previous Therapy: A Phase 3 Trial
- (2014) Xavier Forns et al. GASTROENTEROLOGY
- Patient-reported outcomes in chronic hepatitis C patients with cirrhosis treated with sofosbuvir-containing regimens
- (2014) Zobair M. Younossi et al. HEPATOLOGY
- Citalopram for the Prevention of Depression and Its Consequences in HIV-Hepatitis C Coinfected Individuals Initiating Pegylated Interferon/Ribavirin Therapy: A Multicenter Randomized Double-Blind Placebo-Controlled Trial
- (2014) Marina B. Klein et al. HIV CLINICAL TRIALS
- Hepatitis C and Work Impairment
- (2014) Vignan Manne et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Patient-reported outcomes assessment in chronic hepatitis C treated with sofosbuvir and ribavirin: The VALENCE study
- (2014) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial
- (2014) Ira M Jacobson et al. LANCET
- OPERA: responses to peginterferon and ribavirin therapy in a subgroup of interferon-naïve patients with HIV/HCV genotype 2/3 co-infection in Italy
- (2014) Raffaele Bruno et al. LIVER INTERNATIONAL
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3
- (2014) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
- (2014) Kris V. Kowdley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predictive Factors for Sustained Virological Response after Treatment with Pegylated Interferon α-2a and Ribavirin in Patients Infected with HCV Genotypes 2 and 3
- (2014) Claus Niederau et al. PLoS One
- Discrimination by health care workers versus discrimination by others: Countervailing forces on HCV treatment intentions
- (2014) Loren Brener et al. Psychology Health & Medicine
- Asunaprevir-containing regimens for the treatment of hepatitis C virus infection
- (2014) Sheng-Shun Yang et al. Expert Review of Gastroenterology & Hepatology
- Escitalopram for the Prevention of Peginterferon-α2a–Associated Depression in Hepatitis C Virus–Infected Patients Without Previous Psychiatric Disease
- (2013) Martin Schaefer et al. ANNALS OF INTERNAL MEDICINE
- Effects of Sofosbuvir-Based Treatment, With and Without Interferon, on Outcome and Productivity of Patients With Chronic Hepatitis C
- (2013) Zobair M. Younossi et al. Clinical Gastroenterology and Hepatology
- Similar Effectiveness of Boceprevir and Telaprevir Treatment Regimens for Hepatitis C Virus Infection on the Basis of a Nationwide Study of Veterans
- (2013) George N. Ioannou et al. Clinical Gastroenterology and Hepatology
- Longitudinal Effects of Selective Serotonin Reuptake Inhibitor Therapy and Cytokine-Related Depression on Hepatitis C Viral Logs During Antiviral Therapy
- (2013) Omar T. Sims et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- The effect of liver transplantation on fatigue in patients with primary biliary cirrhosis: A prospective study
- (2013) Marco Carbone et al. JOURNAL OF HEPATOLOGY
- Impact of interferon free regimens on clinical and cost outcomes for chronic hepatitis C genotype 1 patients
- (2013) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Minimal impact of sofosbuvir and ribavirin on health related quality of life in Chronic Hepatitis C (CH-C)
- (2013) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Worker Productivity Outcome Measures: OMERACT Filter Evidence and Agenda for Future Research
- (2013) K. Tang et al. JOURNAL OF RHEUMATOLOGY
- Sofosbuvir: the final nail in the coffin for hepatitis C?
- (2013) Michael P Manns et al. LANCET INFECTIOUS DISEASES
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- (2013) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exploratory Study of Oral Combination Antiviral Therapy for Hepatitis C
- (2013) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- (2013) Eric Lawitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Eligibility and Safety of Triple Therapy for Hepatitis C: Lessons Learned from the First Experience in a Real World Setting
- (2013) Benjamin Maasoumy et al. PLoS One
- Psychometric evaluation of the hepatitis C virus patient-reported outcomes (HCV-PRO) instrument: validity, responsiveness, and identification of the minimally important difference in a phase 2 clinical trial
- (2013) Roger T. Anderson et al. QUALITY OF LIFE RESEARCH
- Prevalence of minimal hepatic encephalopathy and quality of life evaluations in hospitalized cirrhotic patients in China
- (2013) Ji-Yao Wang WORLD JOURNAL OF GASTROENTEROLOGY
- Altered quality of life in the early stages of chronic hepatitis C is due to the virus itself
- (2013) Edna Strauss et al. Clinics and Research in Hepatology and Gastroenterology
- Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review
- (2013) Viktor Mravcik et al. Patient Preference and Adherence
- The Risk of Long-term Morbidity and Mortality in Patients With Chronic Hepatitis C
- (2013) Jeffrey McCombs et al. JAMA Internal Medicine
- The Burden of Untreated Hepatitis C Virus Infection: A US Patients’ Perspective
- (2012) Antoine C. El Khoury et al. DIGESTIVE DISEASES AND SCIENCES
- The burden of viral hepatitis C in Europe
- (2012) Marco daCosta DiBonaventura et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Hepatitis C treatment and SVR: the gap between clinical trials and real-world treatment aspirations
- (2012) Carol S. North et al. GENERAL HOSPITAL PSYCHIATRY
- Factors related to quality of life in patients with cirrhosis and ascites: Relevance of serum sodium concentration and leg edema
- (2012) Elsa Solà et al. JOURNAL OF HEPATOLOGY
- The Burden of Illness for Patients with Viral Hepatitis C: Evidence from a National Survey in Japan
- (2012) Gordon G. Liu et al. VALUE IN HEALTH
- Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study
- (2011) A. Sanyal et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The Results of Phase III Clinical Trials With Telaprevir and Boceprevir Presented at the Liver Meeting 2010: A New Standard of Care for Hepatitis C Virus Genotype 1 Infection, But With Issues Still Pending
- (2011) Jean–Michel Pawlotsky GASTROENTEROLOGY
- Health utilities and psychometric quality of life in patients with early- and late-stage hepatitis C virus infection
- (2011) Priscilla C Hsu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Previous overt hepatic encephalopathy rather than minimal hepatic encephalopathy impairs health-related quality of life in cirrhotic patients
- (2011) Federica Moscucci et al. LIVER INTERNATIONAL
- Barriers to hepatitis C treatment
- (2011) Christopher E. McGowan et al. LIVER INTERNATIONAL
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- The impact of hepatitis C on labor force participation, absenteeism, presenteeism and non-work activities
- (2011) Marco daCosta DiBonaventura et al. JOURNAL OF MEDICAL ECONOMICS
- Extrapyramidal signs predict the development of overt hepatic encephalopathy in patients with liver cirrhosis
- (2010) Luis Compañy et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Quality of life in cirrhosis is related to potentially treatable factors
- (2010) Iñigo Les et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Evaluation of Medication Adherence and Quality of Life in Patients With Hepatitis C Virus Receiving Combination Therapy
- (2010) Jennifer L. Rodis et al. Gastroenterology Nursing
- Using qualitative methods to inform the trade-off between content validity and consistency in utility assessment: the example of type 2 diabetes and Alzheimer's Disease
- (2010) Clare Mcgrath et al. Health and Quality of Life Outcomes
- The impact of hepatitis C virus infection on work absence, productivity, and healthcare benefit costs
- (2010) Jun Su et al. HEPATOLOGY
- Insurance status and treatment candidacy of hepatitis C patients: Analysis of population-based data from the United States
- (2010) Maria Stepanova et al. HEPATOLOGY
- Psychological Determinants of Health-Related Quality of Life in Patients With Chronic Liver Disease
- (2010) J. J. Gutteling et al. PSYCHOSOMATICS
- Predictors of health-related quality of life in patients with chronic liver disease
- (2009) A. AFENDY et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Sustained Responders Have Better Quality of Life and Productivity Compared With Treatment Failures Long After Antiviral Therapy for Hepatitis C
- (2009) Ava A John-Baptiste et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Health-Related Quality of Life Predicts Mortality in Patients With Advanced Chronic Liver Disease
- (2009) Fasiha Kanwal et al. Clinical Gastroenterology and Hepatology
- Psychiatric Problems in Patients Infected with Hepatitis C Before and During Antiviral Treatment with Interferon-Alpha: A Review
- (2009) Rosa Quelhas et al. Journal of Psychiatric Practice
- A Methodology for Successfully Producing Global Translations of Patient Reported Outcome Measures for Use in Multiple Countries
- (2009) Rebecca Two et al. VALUE IN HEALTH
- Management of Chronic Hepatitis C in Veterans: The Potential of Integrated Care Models
- (2008) Samuel B. Ho et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Impact of chronic liver disease and cirrhosis on health utilities using SF-6D and the health utility index
- (2008) Amy A. Dan et al. LIVER TRANSPLANTATION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started